PON2, a membrane-bound enzyme with antioxidant properties, is overexpressed in HNSCC tissues [36] and has been shown to promote tumor cell survival by mitigating mitochondrial ROS production and preventing apoptosis [37]. The gene discussed is PON2; the disease is neoplasm.